Lantheus (LNTH) Stock: Buy, Sell, or Hold?
$101.62
+0.61 (+0.60%)
▲
5d:
+0.81%
30d:
+1.51%
90d:
+0.88%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect LNTH Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (59%)
Quality Score
49/100
Position
EXTENDED
30-Day Fair Range
$99.87 – $100.73
Position: EXTENDED
Forward P/E & Valuation
15.7x
FAIR
vs 14.2x historical avg
Wall Street Target
$106.99
+5.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$99.96 / $101.69
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: LNTH shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When LNTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$165.38
Based on 12.6% avg growth
INTRINSIC VALUE TODAY
$102.69
1.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LNTH is currently trading at $101.62, which is considered extended relative to its 30-day fair value range of $99.87 to $100.73. From a valuation perspective, the stock is trading at a premium (Forward PE: 15.7) compared to its historical average (14.2). At these levels, the market is pricing in 3.3% annual earnings growth.
Technical Outlook: Technically, LNTH is in a strong downtrend. The price is currently testing key support at $99.96. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LNTH is in a strong downtrend. The price is currently testing key support at $99.96. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$99.87 -
$100.73
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
59.2%
Trading Range & Key Levels
30-Day Trading Range
$99.87 -
$100.73
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$2.24
(2.2%)
Support Level
$99.96
Resistance Level
$101.69
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding LNTH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (57/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($106.99)
- BULLISH: Expecting earnings turnaround to 3.3% growth with 1.5% revenue growth
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
15.68
Wall Street Target
$106.99
(+5.3%)
Revenue Growth (YoY)
1.5%
Earnings Growth (YoY)
-19.5%
Profit Margin
17.3%
Valuation Premium vs History
+3.3% premium
PE vs Historical
15.7 vs 14.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.3%
(market-implied from PE analysis)
1-Year Target
$104.97
(+3%)
2-Year Target
$108.44
(+7%)
3-Year Target
$112.02
(+10%)
3-Yr Target (if PE normalizes)
(PE: 16→14)
PE COMPRESSION
$101.45
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 21.2%)
$229.14
(+126%)
Base:
(SPY PE: 15.7, Growth: 21.2%)
$180.90
(+78%)
Bear:
(PE: 13.3, Growth: 21.2%)
$153.76
(+51%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 25.13 | Current EPS (TTM): $4.02
Bull Case
$179.15
(+76%)
Analyst growth 61.2%, PE expands to 27.6
Base Case
$162.86
(+60%)
Market implied 61.2%, PE stable at 25.1
Bear Case
$68.69
(-32%)
Severe decline -20.0%, PE contracts to 21.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share LNTH Analysis
Share this live LNTH analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (LNTH)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 4, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits message highlights Lantheus' potential re-rating due to upcoming clinical catalysts and an undervalued clinical pipeline at a current price of $0.90.
Key Retail Themes:
Lantheus' clinical pipeline
Upcoming clinical catalysts
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:54 AM ET
Data refreshes hourly during market hours. Next update: 8:54 AM
Data refreshes hourly during market hours. Next update: 8:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LNTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 28 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 38 SELL |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 41 HOLD |
|
AMLX
Amylyx Pharmaceuticals I… |
STRONG BUY
12 analysts |
$43 | 45 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 51 HOLD |
Advanced LNTH Option Strategies
Professional options setups generated by AI based on today's LNTH price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive LNTH Research Pages
